Trial Profile
Off-label nab-paclitaxel + gemcitabine chemotherapy in advanced pancreatic cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2015 New trial record